Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP LitigationLife Sciences

Law 360: A Dive Into BPCIA Confidential Info Disclosure Requirements

March 15, 2017

IP LitigationLife Sciences

Law 360: A Dive Into BPCIA Confidential Info Disclosure Requirements

March 15, 2017

Back to Fish's Litigation Blog

 

In a recent Law 360 article, Fish attorneys Tasha Francis and Will Orlady discuss the BPCIA Confidential Info Disclosure Requirements. They explore the riddle contained in the first step of the patent dance by looking at three elements:

  1. the statutory language governing the exchange of confidential information.
  2. what parties have done in litigation so far to satisfy this requirement.
  3. what issues remain for future litigants to navigate.

To read the full article, visit Law 360.

Related Tags

BPCIA
Amgen
patent dance
biologics

Blog Authors

Headshot
Tasha M. Francis, Ph.D. | Associate

Tasha Francis, Ph.D., an associate in Fish & Richardson’s Twin Cities office, practices intellectual property litigation with an emphasis on patent litigation. Dr. Francis has represented plaintiffs and defendants in cases involving medical devices, biotechnology, and...

Headshot
Will Orlady | Associate

Will Orlady is a litigation associate in Fish & Richardson’s Twin Cities office. Mr. Orlady was previously a summer associate with the firm, in which he collaborated to research and brief a matter on appeal to the Federal Circuit. He also analyzed novel issues related to...

Leave a Reply

Your email address will not be published. Required fields are marked *